KALA BIO, Inc. — Balance Sheet Charts
16 snapshots of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-37.7% -$53M
$87M
Current Assets↓-30.9% -$38M
$86M
Cash & Equivalents↓-23.5% -$22M
$70M
ST Investments↓-60.0% -$3M
$2M
Receivables↓-98.7% -$15M
$195K
Inventory↓-100.0% -$8M
$0
Net PPE↓-85.3% -$2M
$400K
Total Liabilities↓-44.7% -$55M
$68M
Current Liabilities↓-31.4% -$12M
$26M
Account Payables↓-42.2% -$2M
$3M
Long-Term Debt↓-52.6% -$42M
$38M
Stockholders Equity↑+12.9% +$2M
$19M
Retained Earnings↓-8.3% -$45M
$-587M
Operating Lease ROU Asset↓-98.8% -$1M
$16K
Operating Lease Liability↓-97.6% -$535K
$13K
Gross PP&E↓-70.9% -$4M
$2M
Accumulated Depreciation↓-57.2% -$2M
$1M
Inventory Raw Materials↑+33.1% +$329K
$1M
Inventory WIP↑+4.7% +$436K
$10M
Inventory Finished Goods↓-99.6% -$6M
$25K
Debt Due Y1
$5M
Debt Due Y2
$5M
Debt Due Y3↑+439.3% +$20M
$24M
Debt Due Y4↓-81.3% -$43M
$10M
Debt Due Y5
$22M
Debt Due >Y5
—
Total Debt Carrying Amount↓-45.9% -$37M
$43M